Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy

Bryan R Conway1, Jillian Rennie, Matthew A Bailey

  • 1MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, Scotland, UK. bryan.conway@ed.ac.uk

Insights

Rodent models poorly mimic human diabetic nephropathy. Combining induced hypertension with diabetes in rats successfully recapitulated key human disease features, offering a better model for studying diabetic kidney disease therapies.

Area of Science:

  • Nephrology
  • Endocrinology
  • Translational Medicine

Background:

  • Rodent models of diabetic nephropathy (DN) display limited human disease features, hindering therapeutic development.
  • Hypertension is crucial for advanced human DN but rare in standard rodent models, contributing to their resistance.
  • The Cyp1a1mRen2 rat, a transgenic model, allows for induced hypertension via dietary indole-3-carbinol.

Purpose of the Study:

  • To develop a more accurate rodent model for human diabetic nephropathy.
  • To investigate the synergistic effects of hyperglycemia and renin-dependent hypertension on kidney damage.
  • To evaluate the utility of the Cyp1a1mRen2 rat for modeling human DN.

Main Methods:

  • Induction of diabetes using streptozotocin in Cyp1a1mRen2 rats.
  • Induction of moderate hypertension using dietary indole-3-carbinol.
  • Assessment of albuminuria, renal histology, and gene expression in diabetic rats with and without induced hypertension.

Main Results:

  • Diabetes alone in rats caused mild kidney changes despite hyperglycemia and increased albuminuria.
  • Concomitant diabetes and induced hypertension led to a significant increase in albuminuria (500-fold).
  • Hypertension and hyperglycemia synergistically induced glomerulosclerosis, tubulointerstitial fibrosis, and gene expression patterns mirroring human DN.

Conclusions:

  • Rodent models of diabetes alone are insufficient for modeling advanced human diabetic nephropathy.
  • The combination of renin-dependent hypertension and hyperglycemia in the Cyp1a1mRen2 rat effectively recapitulates key aspects of human DN.
  • This enhanced rodent model provides a valuable platform for investigating novel therapeutic strategies for diabetic kidney disease.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes Insipidus II: Pathophysiology01:22

Diabetes Insipidus II: Pathophysiology

Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...